OneCell Diagnostics is now 1Cell.Ai
Transforming Cancer Care—One Cell at a Time
Our Mission
We are committed to making precision oncology accessible, actionable, and affordable. By fusing scientific rigor with AI-powered technology, we deliver solutions that support earlier detection, personalized treatment, and continuous monitoring.
Traditional cancer diagnostics often miss key molecular signals—but OneCell Ai’s breakthrough AI-driven genomics captures every detail, delivering precision insights when it matters most.
Advanced machine learning deciphers complex cancer profiles, providing comprehensive insights in real-time.
High-resolution single cell analysis uncovers tumor heterogeneity and disease evolution at the molecular level providing actionable insights.
Tailored treatment strategies informed by real-world data utilizing AI-enhanced interpretation.
1Cell SOLO – Single cell Isolation and analysis System
An AI-driven platform for capturing and analyzing individual tumor cells with unmatched precision—enabling high-resolution research in oncology, drug development, and precision medicine.
1Cell iCore Platform – Integrated AI Analytics
A powerful ecosystem for managing complex, data-intensive clinical trials and precision oncology studies, seamlessly integrating multi-omics data.
The Technology
Machine learning models trained on oncology-specific data to enable real-time molecular analysis and predictive insights.
High-resolution insights from individual tumor cells, integrating genomic, transcriptomic, and proteomic data to reveal tumor behavior and heterogeneity.
Advanced tools to process and interpret multi-omics data—connecting biological complexity to actionable clinical insights.
Automated, algorithm-driven image analysis that improves diagnostic accuracy, consistency, and speed in tissue evaluation.
Immediate delivery of molecular findings to support timely decisions in research, drug design and development , and treatment planning.
A scalable, modular platform for managing precision oncology data across clinical trials, research studies, and lab workflows.
Our Solutions
At 1Cell.Ai, we deliver scalable, AI-powered solutions designed to meet the unique needs of clinicians and oncologists, pharma and bio-pharma industry partners, KOLs, and researchers, and for cancer patients. Our platform turns complex molecular data into real-time, actionable insights—impacting care at every level.
For Clinicians & Oncologists
Non-invasive, real-time molecular alteration information to personalize therapy decisions and continuously monitor disease progression.
For Pharma and Bio-pharma Partners
Multi-omics data integration with true single cell resolution and AI analytics accelerate biomarker discovery, patient stratification, and targeted drug development.
For KOLs and Researchers
Tailored algorithms and advanced data models designed to solve specific clinical and research challenges in oncology.
For Cancer Patients
The ultimate beneficiaries—receiving earlier diagnoses, more personalized treatment and real-time treatment response and therapy monitoring and better long-term outcomes driven by science and AI.
Patient: 7-year-old male with glioblastoma multiforme (WHO Grade IV) post–partial resection and chemoradiotherapy Clinical Testing:Alterations: TP53, CDKN2A, LATS1, ATM, BRCA2, RAD50, MSH2, MLH1, PMS2, XPC,
Patient: 55 years – Female with metastatic triple-negative breast carcinoma (ER–, PR–, HER2 1+) Clinical Testing:Alterations: TP53 (p.D281E), MSH3 (p.R454*), PIK3CA (p.E542K), SMAD4 (p.E307*), SMARCA4 (p.D1127H), NF2
Patient: 52 years – Female with recurrent metastatic breast carcinoma (ER+, HER2–) Clinical Testing:Alterations: ESR1 (mutation), PIK3CA (VUS)Genes: ESR1, PIK3CATreatment Options: Sequential use of SERD/AI ± CDK4/6 inhibitors ±
Strategic Partnerships Driving Best-in-Class Innovation
